MYC and inflammatory breast carcinoma: Particularly, the lack of hormone sensitive, luminal-type preclinical models for IBC is worrisome, since data indicate that ER may contribute to IBC biology in a specific manner as shown by the ER-dependency of MYC expression and transcriptional activity in patient samples.